https://www.kct.fi/ 2024-08-23T12:48:39+00:00 https://www.kct.fi/contact-2/ 2026-02-03T10:17:44+00:00 https://www.kct.fi/privacy-policy/ 2026-03-24T10:25:05+00:00 https://www.kct.fi/competence-ecosystem/analytical-core/ 2024-01-29T13:36:27+00:00 https://www.kct.fi/competence-ecosystem/cell-therapy/ 2024-01-29T13:34:31+00:00 https://www.kct.fi/competence-ecosystem/gene-therapy/ 2023-11-07T11:34:06+00:00 https://www.kct.fi/contact/ 2026-02-04T08:43:11+00:00 https://www.kct.fi/publications-news/ 2023-11-07T11:42:45+00:00 https://www.kct.fi/science/ 2023-10-26T04:57:49+00:00 https://www.kct.fi/competence-ecosystem/ 2024-08-23T12:51:09+00:00 https://www.kct.fi/about-us/ 2026-02-04T08:55:33+00:00 https://www.kct.fi/2025/05/09/hiring-scientist-cell-therapy-group/ 2025-05-09T10:07:43+00:00 https://www.kct.fi/2024/10/07/ferring-ventures-and-university-of-eastern-finland-to-continue-collaboration-in-cell-therapy-research/ 2024-10-07T13:11:51+00:00 https://www.kct.fi/2024/08/13/hiring-site-operations-specialist-hr/ 2024-08-23T12:53:31+00:00 https://www.kct.fi/2023/09/28/cytokines-impact-natural-killer-cell-phenotype-and-functionality-against-glioblastoma-in-vitro/ 2024-01-30T07:17:29+00:00 https://www.kct.fi/2021/11/22/university-of-eastern-finland-and-ferring-ventures-continue-their-collaboration-in-gene-and-cell-therapy-research/ 2024-01-30T06:59:23+00:00 https://www.kct.fi/2021/10/26/peptichip-a-microfluidic-platform-for-tumor-antigen-landscape-identification/ 2024-01-30T07:17:36+00:00 https://www.kct.fi/2020/08/20/transcriptomics-uncovers-substantial-variability-associated-with-alterations-in-manufacturing-processes-of-macrophage-cell-therapy-products/ 2024-01-30T07:17:44+00:00 https://www.kct.fi/2020/03/30/set-the-title-here/ 2024-01-30T06:51:22+00:00 https://www.kct.fi/2020/02/19/benchmarking-of-scale%e2%80%90x-bioreactor-system-in-lentiviral-and-adenoviral-vector-production/ 2024-01-30T06:53:01+00:00 https://www.kct.fi/2020/01/07/riikka-nivajarvi-venla-olsson-viivi-hypponen-sean-bowen-hanna-m-leinonen-hanna-p-lesch-jan-henrik-ardenkjaer%e2%80%90larsen-olli-h-j-grohn-seppo-yla%e2%80%90herttuala-mikko-i-kettunen/ 2024-01-30T06:51:58+00:00 https://www.kct.fi/2019/08/29/preclinical-proof-of-concept-analytical-development-and-commercial-scale-production-of-lentiviral-vector-in-adherent-cells/ 2024-01-30T06:53:46+00:00 https://www.kct.fi/2018/12/04/back-to-the-future-where-are-we-taking-lentiviral-vector-manufacturing/ 2024-01-30T06:55:51+00:00 https://www.kct.fi/2018/08/06/welcome-to-the-kuopio-center-for-gene-and-cell-therapy/ 2024-01-30T06:57:05+00:00 https://www.kct.fi/2018/03/14/optimization-of-lentiviral-vector-production-for-scale-up-in-fixed-bed-bioreactor-2/ 2024-01-30T06:58:59+00:00 https://www.kct.fi/2018/01/25/optimization-of-lentiviral-vector-production-for-scale-up-in-fixed-bed-bioreactor/ 2024-01-30T06:57:41+00:00 https://www.kct.fi/2017/10/18/viral-vector-particle-integrity-and-purity-analysis-in-early-process-development/ 2024-01-30T06:50:03+00:00